CNBX PHARMACEUTICALS INC. Proceeds from Issuance or Sale of Equity
CNBX PHARMACEUTICALS INC. (CNBX) reported Proceeds from Issuance or Sale of Equity of $30.00 thousand for the 3-month period ending 2024-11-30, per its 10-Q filed 2025-01-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-01-13
- CNBX PHARMACEUTICALS INC. proceeds from issuance or sale of equity for the quarter ending 2024-11-30 was $30.00K, a 20.03% increase year-over-year.
- CNBX PHARMACEUTICALS INC. proceeds from issuance or sale of equity for the quarter ending 2023-11-30 was $24.99K.
- CNBX PHARMACEUTICALS INC. proceeds from issuance or sale of equity for the quarter ending 2014-05-31 was $1.98K.
- CNBX PHARMACEUTICALS INC. proceeds from issuance or sale of equity for the quarter ending 2014-02-28 was $1.00K.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 116 month |
|---|---|---|---|---|
| 2024-11-30 | $30.00K 10-Q · filed 2025-01-13 | |||
| 2024-05-31 | $0.00 10-Q · filed 2024-07-15 | |||
| 2023-11-30 | $24.99K 10-Q · filed 2025-01-13 | |||
| 2023-05-31 | $0.00 10-Q · filed 2024-07-15 | |||
| 2019-05-31 | $7.50M 10-Q · filed 2019-07-15 | |||
| 2014-05-31 | $1.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-15 | $2.98K derived: sum of 2 quarters · filed 2014-07-15 | $102.98K 10-Q · filed 2014-07-15 | $463.88K 10-Q · filed 2014-07-15 |
| 2014-02-28 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-01 | $101.00K 10-Q · filed 2014-04-01 | ||
| 2013-11-30 | $100.00K 10-Q · filed 2014-01-14 | |||
| 2013-05-31 | $0.00 10-Q · filed 2014-07-15 |